Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(4):253-254; doi:10.1093/jnci/97.4.253
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Christensen, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christensen, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

NEWS

Umbilical Cord Blood Offers Another Option for Leukemia Patients

Damaris Christensen

The first 10% of the full text of this article appears below.

Adults with leukemia who need hematopoietic stem cell transplants but do not have bone marrow donors matched for key immune antigens will fare equally well with transplants that use bone marrow grafts that are mismatched for one antigen or that use stem cell–rich blood taken from umbilical cords soon after birth, according to two new studies. These are the first large-scale studies to compare cord blood transplants to current standard therapy in adults with leukemia.

"Cord blood opens the door to provide transplants to thousands of leukemia patients who otherwise would not get a transplant," said Mary J. Laughlin, M.D., of the Case Comprehensive Cancer Center in Cleveland. Only about 30% of leukemia patients who are eligible for transplants . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?